Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ritalin LA under different breakfast conditions in children with ADHD
2006-006441-14Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Novartis. Primary endpoint: Teacher-rated FBB-ADHS after one week. Started Mar 2007; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2006-006441-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006441-14.